论文部分内容阅读
目的 :探讨经靶动脉灌注碳酸氢钠是否能减轻肝癌介入治疗的不良反应;方法:回顾性分析使用和未使用碳酸氢钠的肝癌介入治疗患者各25名,将术后发生不良反应的进行统计分析对比;结果:使用碳酸氢钠的患者不良反应程度明显减轻;结论:经靶动脉灌注碳酸氢钠可明显减轻肝癌介入治疗患者的不良反应。
Objective: To investigate whether transarterial sodium bicarbonate infusion can reduce the adverse reaction of interventional therapy for hepatocellular carcinoma (HCC). Methods: Twenty-five patients with hepatocellular carcinoma (HCC) treated with and without sodium bicarbonate were retrospectively analyzed. The incidence of postoperative adverse reactions Results: The degree of adverse reactions in patients with sodium bicarbonate significantly reduced; Conclusion: The infusion of sodium bicarbonate through the target artery can significantly reduce the adverse reactions of patients with liver cancer interventional therapy.